Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil vs Remifentanil in PCS During ERCP
NCT01350037Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Jun 2009
- Primary completion
- Sep 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of alfentanil, remifentanil in biliary tract diseases, sponsored by Helsinki University Hospital. Started Jun 2009; status: completed.
02
Drugs
alfentanilremifentanil
03
Conditions
biliary tract diseases
Beyond the preview
Go deeper on NCT01350037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01350037.